๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Proprotein convertase genes in Xenopus development

โœ Scribed by Sylvia Nelsen; Linnea Berg; Crispin Wong; Jan L. Christian

Book ID
102819640
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
626 KB
Volume
233
Category
Article
ISSN
1058-8388

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Proprotein Convertases in Health and Dis
Proprotein Convertases in Health and Disease
โœ Artenstein, Andrew W.; Opal, Steven M. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 715 KB
Inhibition of proprotein convertases: Ap
Inhibition of proprotein convertases: Approaches to block squamous carcinoma development and progression
โœ Ricardo Lรณpez de Cicco; Daniel E. Bassi; Fernando Benavides; Claudio J. Conti; A ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

## Abstract Most proprotein convertase (PC) inhibitors are compounds that act as competitive inhibitors. All of them contain the general cleavage motif RXK/RR that binds to the PC's active site impairing further interactions with their physiological substrates. The first inhibitors synthesized were

Proprotein convertase subtilisin/kexin t
Proprotein convertase subtilisin/kexin type 9: A new target molecule for gene therapy
โœ Anna Banaszewska; Michal Piechota; Robert Plewa ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› SP Versita ๐ŸŒ English โš– 341 KB

## Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a novel target for controlling plasma levels of low-density lipoprotein cholesterol (LDL-C) and decreasing the risk of cardiovascular diseases. At present it is clear that the major classes of commonly prescribed lipid